279 related articles for article (PubMed ID: 3893685)
1. Quantitative genetic analysis of tumor progression.
Ling V; Chambers AF; Harris JF; Hill RP
Cancer Metastasis Rev; 1985; 4(2):173-92. PubMed ID: 3893685
[TBL] [Abstract][Full Text] [Related]
2. Dynamic heterogeneity and metastasis.
Ling V; Chambers AF; Harris JF; Hill RP
J Cell Physiol Suppl; 1984; 3():99-103. PubMed ID: 6589232
[TBL] [Abstract][Full Text] [Related]
3. Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype.
Young SD; Hill RP
Clin Exp Metastasis; 1986; 4(3):153-76. PubMed ID: 3742890
[TBL] [Abstract][Full Text] [Related]
4. Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor.
Harris JF; Chambers AF; Hill RP; Ling V
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5547-51. PubMed ID: 6957880
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability.
Cillo C; Ling V; Hill RP
Int J Cancer; 1989 Jan; 43(1):107-11. PubMed ID: 2910823
[TBL] [Abstract][Full Text] [Related]
6. Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.
Korycka BM; Hill RP
Clin Exp Metastasis; 1989; 7(1):107-16. PubMed ID: 2908825
[TBL] [Abstract][Full Text] [Related]
7. Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells.
Hill RP; Chambers AF; Ling V; Harris JF
Science; 1984 Jun; 224(4652):998-1001. PubMed ID: 6719130
[TBL] [Abstract][Full Text] [Related]
8. Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.
Cillo C; Dick JE; Ling V; Hill RP
Cancer Res; 1987 May; 47(10):2604-8. PubMed ID: 3567893
[TBL] [Abstract][Full Text] [Related]
9. Dynamic heterogeneity: characterization of two cell lines derived from experimental lung metastases of mouse KHT fibrosarcoma.
Harris JF; Chambers AF; Ling V; Hill RP
Invasion Metastasis; 1987; 7(4):217-29. PubMed ID: 3667144
[TBL] [Abstract][Full Text] [Related]
10. Increased spontaneous mutation rates and prevalence of karyotype abnormalities in highly metastatic human melanoma cell lines.
Bailly M; Bertrand S; Doré JF
Melanoma Res; 1993 Feb; 3(1):51-61. PubMed ID: 8471837
[TBL] [Abstract][Full Text] [Related]
11. Tumor heterogeneity and drug resistance.
Dexter DL; Leith JT
J Clin Oncol; 1986 Feb; 4(2):244-57. PubMed ID: 3944607
[TBL] [Abstract][Full Text] [Related]
12. Generation of metastatic variants in populations of mutator and amplificator mutants.
Damen JE; Tagger AY; Greenberg AH; Wright JA
J Natl Cancer Inst; 1989 Apr; 81(8):628-31. PubMed ID: 2704053
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability and metastatic progression.
Usmani BA
Pathobiology; 1993; 61(2):109-16. PubMed ID: 8216826
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
Poste G
Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
[TBL] [Abstract][Full Text] [Related]
15. Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.
Larizza L; Schirrmacher V
Cancer Metastasis Rev; 1984; 3(3):193-222. PubMed ID: 6388823
[TBL] [Abstract][Full Text] [Related]
16. Metastatic potential and spontaneous mutation rates: studies with two murine cell lines and their recently induced metastatic variants.
Kendal WS; Frost P
Cancer Res; 1986 Dec; 46(12 Pt 1):6131-5. PubMed ID: 3779633
[TBL] [Abstract][Full Text] [Related]
17. Dynamic heterogeneity: metastatic variants to liver are generated spontaneously in mouse embryonal carcinoma cells.
Harris JF; Best MW
Clin Exp Metastasis; 1988; 6(6):451-62. PubMed ID: 2900709
[TBL] [Abstract][Full Text] [Related]
18. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction.
Zijlstra A; Mellor R; Panzarella G; Aimes RT; Hooper JD; Marchenko ND; Quigley JP
Cancer Res; 2002 Dec; 62(23):7083-92. PubMed ID: 12460930
[TBL] [Abstract][Full Text] [Related]
19. The Ernst W. Bertner Memorial Award lecture: the evolution of biological heterogeneity in metastatic neoplasms.
Fidler IJ
Symp Fundam Cancer Res; 1983; 36():5-26. PubMed ID: 6382521
[TBL] [Abstract][Full Text] [Related]
20. Experimental systems for analysis of the malignant phenotype.
Poste G
Cancer Metastasis Rev; 1982; 1(2):141-99. PubMed ID: 6764376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
